Acmeware Achieves 100% Submission Success
Featured article
Acmeware completes 100% successful submissions for eCQM, PQRS, Hospital IQR, and Joint Commission ORYX using OneView for acute and ambulatory settings.
The FY 2023 IPPS Final Rule confirms significant updates to hospital quality reporting and promoting interoperability requirements.
Article content
CMS recently published the FY 2023 Inpatient Prospective Payment System (IPPS) Final Rule which includes several changes to the Hospital Inpatient Quality Reporting (IQR) Program and Medicare Promoting Interoperability Program for eligible hospitals and critical access hospitals (CAHs). For the full text of the rule, see the Federal Register.
CMS finalized numerous changes related to the IQR Program including the adoption of ten new measures and the refinement of two existing measures.
CMS finalized ten new measures with voluntary and mandatory reporting periods beginning with the CY 2023 reporting year.

CMS finalized refinements to two measures beginning with the FY 2024 payment determination:
CMS finalized establishing a hospital quality designation for maternity care to be publicly reported beginning fall of 2023.
Beginning with the CY 2024 reporting period / FY 2026 payment determination, CMS finalized increasing eCQM reporting from four to six eCQMs (three mandatory and three self-selected).
CMS finalized modifying the eCQM validation policy beginning with CY 2022 data by increasing the submission requirement from 75% to 100% of requested medical records.
CMS finalized several changes to the PI Program beginning with the CY 2023 EHR Reporting Period:
Scoring changes: Public Health and Clinical Data Exchange increased from 10 to 25 points; Electronic Prescribing increased from 10 to 20; Health Information Exchange reduced from 40 to 30; Provide Patients Electronic Access reduced from 40 to 25.

CMS also finalized adoption of new eCQMs and modified reporting requirements in alignment with IQR.
If you have questions about your hospital reporting, please contact us.